Anterra Capital Hits €86M First Close on Agrifoodtech Fund III
TL;DR
Amsterdam's Anterra Capital, a specialist food-and-agriculture venture firm co-founded and led by Managing Partner Adam Anders, has reached a €86 million ($100 million) first close on Fund III against a €172 million ($200 million) target. The LP base reads like a who's-who of the food system, anchored by Rabobank, Novo Holdings and Zoetis, with operator LPs that collectively farm more than 13 million acres. Founded in 2013, Anterra now manages roughly €430 million ($500 million) across three funds and is leaning hard into how AI is reshaping food and agriculture.
Key Takeaways
Half-raised on a debut close in a frozen agtech market is a statement. Hitting 50% of target at first close, while agtech valuations have reset toward 2016 levels, signals that strategic LPs are treating the downturn as an entry point. Specialist funds with real domain credibility are still getting funded; generalists chasing the same deals are not.
The LP base is the moat. Rabobank, Novo Holdings and Zoetis are not passive capital. They are the distribution, scientific and animal-health backbone of the global food system, and operator LPs farming 13 million-plus acres give Anterra a built-in pilot and commercialization network most agtech funds cannot replicate.
AI is the explicit thesis, not a bolt-on. Anterra is framing Fund III around life-science and software innovation applied to food and agriculture, positioning AI as the lever that finally makes precision agriculture and biological discovery economically viable at scale.
Discipline through the cycle. A firm that raised a $260 million Fund II at the peak and is now closing a tighter, more concentrated Fund III is demonstrating portfolio discipline rather than asset-gathering, which is exactly what LPs want from a specialist in a battered category.
Fund Overview
Fund Name: Anterra Capital Fund III
Fund Size: €86 million ($100 million) first close; €172 million ($200 million) target
Stage: Venture and growth across agrifoodtech
Check Size: Undisclosed for Fund III
Geography: North America, Europe and APAC
Focus: Life-science and software innovation applied to food and agriculture, including AI-driven agtech
Key LPs: Rabobank, Novo Holdings, Zoetis, plus operator LPs farming 13M+ acres
Why This Fund Matters
Agrifoodtech has been one of the most punished corners of venture over the past three years. Capital that rushed in around 2021 on vertical-farming and food-delivery hype retreated just as fast, dragging valuations across the entire category back toward levels last seen in 2016. Into that vacuum, a specialist with a decade of track record and a strategically aligned LP base is exactly the kind of investor that tends to generate vintage-year returns. The best agtech entries have historically been made when generalist money is fleeing.
What separates Anterra from the tourists is the depth of its strategic LP relationships. Rabobank is arguably the most important financial institution in global agriculture; Novo Holdings brings life-science and biological capital; Zoetis anchors animal health. When your LPs are also your portfolio companies' most logical commercial partners and acquirers, you compress the path from pilot to scale in a way pure financial funds cannot. The operator LPs farming millions of acres are effectively a captive testbed for any precision-agriculture or biologicals company in the portfolio.
The AI framing is more than marketing here. Food and agriculture is a roughly $10 trillion industry that has been structurally under-digitized, and the recent leap in machine learning is finally making applications viable that were science projects a few years ago: AI-accelerated trait discovery, autonomous field robotics, predictive supply-chain and biological design. Anterra's life-science-plus-software DNA positions it to underwrite exactly these bets with technical conviction.
There is a counter-cyclical elegance to the timing. Raising a more concentrated Fund III after a $260 million Fund II is not a step back; it is a recognition that in a reset market, smaller and sharper beats larger and sprayed. The discipline should translate into better ownership and entry prices on a cohort of companies built lean through the downturn.
The Team
Anterra Capital was co-founded in 2013 and is led by Managing Partner Adam Anders, who brings more than two decades of private equity and venture experience focused on transforming the safety, security and sustainability of the global food system. The firm has built its reputation as one of the few genuinely specialist agrifoodtech investors with the scientific literacy to underwrite both biological and software innovation, and the LP relationships, particularly Rabobank and Zoetis, reflect more than a decade of operating inside the food and animal-health industries rather than adjacent to them.
Early Portfolio
Anterra has deployed across three funds since 2013, building a portfolio spanning agricultural biotechnology, animal health and digital tools for the food value chain. Fund III's specific initial investments were not detailed at first close, but the firm's stated focus on AI-enabled agriculture and life-science innovation signals where the new capital will be concentrated.
What This Means for Founders
If you are building in agrifoodtech, biologicals, animal health or AI-for-agriculture, Anterra is one of the few funds that can genuinely accelerate you rather than just capitalize you. Access to Rabobank's reach, Zoetis's animal-health platform and operator LPs farming millions of acres means a pilot can become a commercial deployment without you cold-starting every relationship. In a category where distribution and trust are the hardest things to build, that network is the differentiator.
The flip side is fit. Anterra is a specialist with a clear scientific and strategic thesis, which means founders outside the food-and-agriculture core, or those without a defensible technical edge, are not the target. Pitch Anterra if your company benefits from deep agricultural distribution and life-science credibility; look elsewhere if you need a generalist who will move fast on a thin thesis.
Fund Momentum Take
We are bullish on this one, and our reasoning is simple: specialist funds with strategic LP moats raising into a reset market are the classic setup for strong vintages. Anterra is not trying to time a recovery; it is buying a discounted cohort with a captive commercialization network attached. The 50%-of-target first close in a frozen agtech environment is a quiet vote of confidence from LPs who know the sector cold.
The risks are equally clear. Agrifoodtech exit timelines are long, the public-market comps remain ugly, and even a strategically anchored fund cannot manufacture liquidity in a category where M&A has slowed. There is also concentration risk in leaning so heavily on a handful of strategic LPs whose own priorities could shift. And the AI thesis, while real, will attract a wave of generalist imitators that compresses entry prices over time.
Our bet: Anterra closes at or near its €172 million target and that Fund III ends up one of the better-performing agtech vintages of the decade, precisely because it was raised when nearly everyone else had given up on the category.
Frequently Asked Questions
How much did Anterra Capital raise at first close?
Fund III reached a €86 million ($100 million) first close against a €172 million ($200 million) target.
Who are the lead investors in Fund III?
Rabobank, Novo Holdings and Zoetis anchor the fund, alongside operator LPs who collectively farm more than 13 million acres.
What does Anterra Capital invest in?
Life-science and software innovation applied to food and agriculture, increasingly centered on AI-enabled agtech, across North America, Europe and APAC.
How much does Anterra manage?
The firm manages roughly €430 million ($500 million) across three funds since its founding in 2013.
Who leads Anterra Capital?
Adam Anders is Managing Partner and co-founder, bringing more than 20 years of private equity and venture experience in the food and agriculture sector.
Have a fund closing to announce? Submit your fund here.
Need help raising capital? Check out our Fundraising Advisory services.